GET THE APP

Prophylactic Risk-Reducing Salpingo-Oophorectomy in Women with BRCA1 or BRCA2 Mutations: A Systematic Review and Meta-Analysis

Journal of Genital System & DisordersISSN: 2325-9728

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Prophylactic Risk-Reducing Salpingo-Oophorectomy in Women with BRCA1 or BRCA2 Mutations: A Systematic Review and Meta-Analysis

Introduction & Objective: Prophylactic risk-reducing Salpingooophorectomy (RRSO) refers to surgical removal of both fallopiantubes and ovaries in women not thought to have cancer prior to surgical procedure but have a high lifetime risk. Despite previous studies, the role of RRSO in reducing breast and High-grade Serous Cancer (HGSC) of ovarian, tubal and peritoneal origin are uncertain. This study assesses benefits and harms of prophylactic RRSO in women with BRCA1 or BRCA2 mutations. Method: We searched Cochrane Central Register of Controlled Trials, MEDLINE /Embase Ovid and trial registries, and abstracts with no language restrictions up to July 2017. We included non-randomized trials that used statistical adjustment analyses comparing RRSO versus no RRSO in women without a previous/coexisting gynecological malignancy and in women with a Risk-reducing Mastectomy (RRM). We extracted data and performed meta-analyses of Hazard Ratios (HR) for time-to-event variables and Risk Ratios (RR) for dichotomous outcomes, with 95% Confidence Intervals (CI). We used ROBINS-I ‘Risk of bias’ assessment tool and quantified inconsistency using I2 statistic. We used random-effects models.

Special Features

Full Text

View

Track Your Manuscript

Media Partners

Associations